Edwards Lifesciences
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.www.edwardslifesciences.com
2
MENTIONS
2
EPISODES
2
PODCASTS
Search complete. 2 mentions across 2 episodes found for "Edwards Lifesciences".
Oct 6, 2026
speaker_0HOST
As a first-line therapy, Japerka introduces a novel mechanism with non-covalent BTK inhibitors, offering new hope for patients resistant to existing treatments.
speaker_0HOST
In medical devices, Edwards Lifesciences' innovative Audus size adjustable valve gained FDA approval for pediatric congenital pulmonary valve disease.
speaker_0HOST
This advancement addresses a critical need for adaptable solutions in managing congenital heart disease in children, potentially reducing the number of invasive procedures they require as they grow.
speaker_0HOST
Collaborations continue to shape the industry landscape.
Paul LoudonGUEST
And we'll not make that right call 100% of the time, but if we make it more than, more than we don't, then, um, you know, that's a decent outcome.
Katie BoyceHOST
[upbeat music] Perhaps the best way to bring that process to life is to talk about a real example, um, Edwards Lifesciences, which treats structural heart disease.
Katie BoyceHOST
It's had a particularly rough couple of years.
Katie BoyceHOST
Perhaps you could explain what happened there.